More Business Wire
View Older Stories View Newer Stories-
LIB Therapeutics Announces Abstracts Accepted for Presentation at the American College of Cardiology Scientific Session 2024
-
Cushman & Wakefield Recognized by Fitwel for 2024 “Best in Building Health” Awards
-
Centivo Announces Ryan Moore as Chief Revenue Officer
-
Reinsurance Group of America Appoints New Member to Board of Directors
-
Understand the Risk of Pests and Proper Prevention Measures this National Pest Management Month
-
Regions Financial Announces John Jordan to Serve as Head of Retail
-
Pembina Pipeline Corporation Announces Closing of Acquisition of Enbridge’s Interest in Alliance/Aux Sable and Raises 2024 Guidance
-
Business Park Sofia Celebrates Wave of New and Renewed Leases
-
BRW Announces $0.085 Dividend
-
SABA Announces $0.029 Dividend
-
Central Valley Community Bancorp Completes Community West Bancshares Merger, Adopts Name, Announces Board and Executive Reorganization
-
Incyte and CMS Announce Collaboration and License Agreement for Povorcitinib, an Oral JAK1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia
-
Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Following Positive Results of PALISADE-2
-
Guerrilla RF Announces Completion of $5.0 Million Private Placement Equity Financing and Related Transactions
-
Clinical Collaboration Agreement between Teva and Launch Therapeutics to Accelerate Development of Dual-Action Asthma Rescue Inhaler (ICS-SABA/TEV-’248) Respiratory Program; Teva and Abingworth Ente
-
Amprius Sets April 2024 Events Schedule
-
Align Technology to Announce First Quarter 2024 Results on April 24, 2024
-
IDC Estimates that GenAI Will Increase Marketing Productivity More Than 40% by 2029
-
Kinder Morgan Announces Amy W. Chronis as Nominee for Election to Board of Directors
-
Hexcel Schedules First Quarter 2024 Earnings Release and Conference Call
-
Westinghouse Announces Executive Management Appointments
-
RioCan Real Estate Investment Trust Schedules First Quarter 2024 Earnings Release, Conference Call and Webcast
-
MN8 Energy LLC Announces Closing of Private Placement
-
taq Automotive Intelligence & LeaseBusters Join Forces to Redefine the Auto Leasing Landscape
-
PharmaJet Announces Scientific Advisory Boards and Presentation at World Vaccine Congress in Washington on April 1
-
Kontrol Technologies Announces Fourth Quarter and Fiscal Year 2023 Financial Results
-
Zyxel Networks Garners Spot in 2024 CRN Partner Program Guide
-
Gary Pestana Joins Alliant Insurance Services as Managing Director in Real Estate Specialty
-
AlTi Tiedemann Global Announces Acquisition of East End Advisors Following Strategic Investment
-
TriSalus Reports Q4 and Full Year 2023 Financial Results and Business Update
-
Masimo Responds to Politan Capital’s Nomination of Director Candidates and Refutes Politan’s False Claims
-
GCT Semiconductor Appoints Nelson C. Chan to Board of Directors
-
Pyros Pharmaceuticals Announces VIGPODER™ (vigabatrin) is Now Available
-
Guerrilla RF Reports Record Revenue for Fourth Quarter and Full Year 2023
-
Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis
-
Zinnia Closes Acquisition of Ebix’s North American Life and Annuity Assets
-
H.I.G. Capital Acquires the Spine Business of ZimVie Rebranded as Highridge Medical
-
Littlejohn & Co. Acquires United Air Temp, Air Conditioning and Heating
-
XRHealth Awarded Contract with Israeli Police To Deploy Solution in Every Police Station Throughout Israel to Promote Mental Health Resilience
-
Herc Holdings Inc. Announces Nomination of Lorin Crenshaw to Board of Directors
-
Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103 (MODERN): A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer
-
Vertex Advances Inaxaplin (VX-147) into Phase 3 Portion of Adaptive Phase 2/3 Clinical Trial for the Treatment of APOL1-Mediated Kidney Disease
-
Western Asset Emerging Markets Debt Fund Inc. (EMD or “the Fund”; CUSIP: 95766A101) Announces Notification of Sources of Distributions
-
Browning West’s Slate of Highly Qualified Director Candidates Releases Five-Pillar Plan to Enhance Shareholder Value at Gildan Activewear
-
Agilent Launches New Advanced Dilution System to Increase Lab Efficiency
-
Twilio Appoints Andy Stafman to Board of Directors
-
Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp
-
Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development
-
Celebrate Vitacost’s 30th Anniversary With the $30K Giveaway Sweepstakes
-
DoorDash Adds Lowe’s as First Home Improvement Retail Partner
